Back
Pharming Group Quote, Financials, Valuation and Earnings
Sponsored
PHAR
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
42
PHAR
Pharming Group
Last Price:
7.54
Seasonality Move:
-9.32%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.Pharming Group Price Quote
$7.54
-0.04 (-6.22%)
(Updated: September 21, 2024 at 6:38 AM ET)
Pharming Group Key Stats
Sell
42
Pharming Group (PHAR)
is a Sell
Day range:
$7.53 - $7.67
52-week range:
$6.65 - $14.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.16
P/B ratio:
2.33%
Volume:
4.4K
Avg. volume:
5.9K
1-year change:
-45.55%
Market cap:
$514.5M
Revenue:
$245.3M
EPS:
$-0.19
How Much Does Pharming Group Make?
-
How Much Are Pharming Group's Sales Annually?
PHAR Revenues are $245.3M -
How Much Profit Does Pharming Group's Make A Year?
PHAR net income is -$10.5M
Is Pharming Group Growing As A Company?
-
What Is Pharming Group's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.35% -
What Is Pharming Group's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Pharming Group Stock Price Performance
-
Did Pharming Group Stock Go Up Last Month?
Pharming Group share price went down by -3.01% last month -
Did PHAR's Share Price Rise Over The Last Year?
PHAR share price fell by -45.55% over the past 1 year
What Is Pharming Group 52-Week High & Low?
-
What Is Pharming Group’s 52-Week High Share Price?
Pharming Group has traded as high as $14.75 over the past 52 weeks -
What Is Pharming Group’s 52-Week Low Share Price?
Pharming Group has traded as low as $6.65 over the past 52 weeks
Pharming Group Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Pharming Group?
-
How Much Debt Does Pharming Group Have?
Total long term debt quarterly is $90.5M -
How Much Cash Does Pharming Group Have?
Cash and short term investments quarterly total is $160.3M -
What Is Pharming Group’s Book Value Per Share?
Book value per share is 3.26
Is Pharming Group Cash Flow Positive?
-
What Is PHAR Cash Flow From Operations?
Cash flow from operations (TTM) is -$5.8M -
What Is Pharming Group’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$26.6M -
What Is Pharming Group’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$25.1M
Pharming Group Return On Invested Capital
-
Is Management Doing A Good Job?
PHAR return on invested capital is -3.95% -
What Is Pharming Group Return On Assets?
ROA measures how assets are converting to revenues and is -3.05% -
What Is PHAR Return On Equity?
ROE is a measure of profitability and is -6.31%
Pharming Group Earnings Date & Stock Price
-
What Is Pharming Group's Stock Price Today?
A single share of PHAR can be purchased today for 7.59 -
What Is Pharming Group’s Stock Symbol?
Pharming Group trades on the nasdaq under the ticker symbol: PHAR -
When Is Pharming Group’s Next Earnings Date?
The next quarterly earnings date for Pharming Group is scheduled on October 24, 2024 -
When Is PHAR's next ex-dividend date?
Pharming Group's next ex-dividend date is September 21, 2024 -
How To Buy Pharming Group Stock?
You can buy Pharming Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Pharming Group Competitors
-
Who Are Pharming Group's Competitors?
Below is a list of companies who compete with Pharming Group or are related in some way:
Pharming Group Dividend Yield
-
What Is PHAR Dividend Yield?
Pharming Group’s dividend yield currently is 0% -
What Is Pharming Group’s Payout Ratio?
Pharming Group’s payout ratio is 0% -
When Did Pharming Group Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is Pharming Group’s Dividend Per Share?
Pharming Group pays a dividend of $0.00 per share
Pharming Group Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 50% |
Revenue: | 34.97% | 2.91% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 34.00 |
Upside from Last Price: | 348.25% |